Chronic urticaria in most patients is poorly controlled: Results of the development, validation, and real life application of the arabic urticaria control test

Carla Irani; Souheil Hallit; Karsten Weller; Marcus Maurer; Carla El Haber; Pascale Salameh

doi:10.15537/smj.2017.12.21206

References

↵
1. Zuberbier T,
2. Aberer W,
3. Asero R,
4. Bindslev-Jensen C,
5. Brzoza Z,
6. Canonica GW,
7. et al.
(2014) The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy 69:868–887.
OpenUrl CrossRef PubMed
↵
1. Maurer M,
2. Weller K,
3. Bindslev-Jensen C,
4. Gimenez-Arnau A,
5. Bousquet PJ,
6. Bousquet J,
7. et al.
(2011) Unmet clinical needs in chronic spontaneous urticaria. A GA(2)LEN task force report. Allergy 66:317–330.
OpenUrl CrossRef PubMed Web of Science
↵
1. Weller K,
2. Groffik A,
3. Church MK,
4. Hawro T,
5. Krause K,
6. Metz M,
7. et al.
(2014) Development and validation of the urticaria control test: a patient-reported outcome instrument for assessing urticaria control. J Allergy Clin Immunol 133:1365–1372.
OpenUrl CrossRef
↵
1. Jauregui I,
2. Ortiz de Frutos FJ,
3. Ferrer M,
4. Gimenez-Arnau A,
5. Sastre J,
6. Bartra J,
7. et al.
(2014) Assessment of severity and quality of life in chronic urticaria. J Investig Allergol Clin Immunol 24:80–86.
OpenUrl
↵
1. Weller K,
2. Siebenhaar F,
3. Hawro T,
4. Altrichter S,
5. Schoepke N,
6. Maurer M
(2017) Clinical measures of chronic urticaria. Immunol Allergy Clin North Am 37:35–49.
OpenUrl
↵
1. Weller K,
2. Zuberbier T,
3. Maurer M
(2015) Clinically relevant outcome measures for assessing disease activity, disease control and quality of life impairment in patients with chronic spontaneous urticaria and recurrent angioedema. Curr Opin Allergy Clin Immunol 15:220–226.
OpenUrl
↵
1. Weller K,
2. Groffik A,
3. Magerl M,
4. Tohme N,
5. Martus P,
6. Krause K,
7. et al.
(2013) Development, validation, and initial results of the Angioedema Activity Score. Allergy 68:1185–1192.
OpenUrl
↵
1. Mlynek A,
2. Magerl M,
3. Hanna M,
4. Lhachimi S,
5. Baiardini I,
6. Canonica GW,
7. et al.
(2009) The German version of the chronic urticaria quality-of-life questionnaire: factor analysis, validation, and initial clinical findings. Allergy 64:927–936.
OpenUrl CrossRef PubMed Web of Science
↵
1. Weller K,
2. Groffik A,
3. Magerl M,
4. Tohme N,
5. Martus P,
6. Krause K,
7. et al.
(2012) Development and construct validation of the angioedema quality of life questionnaire. Allergy 67:1289–1298.
OpenUrl PubMed
↵
1. Weller K,
2. Magerl M,
3. Peveling-Oberhag A,
4. Martus P,
5. Staubach P,
6. Maurer M
(2016) The angioedema quality of life questionnaire (AE-QoL)–assessment of sensitivity to change and minimal clinically important difference. Allergy 71:1203–1209.
OpenUrl
↵
1. Młynek A,
2. Zalewska-Janowska A,
3. Martus P,
4. Staubach P,
5. Zuberbier T,
6. Maurer M
(2008) How to assess disease activity in patients with chronic urticaria? Allergy 63:777–780.
OpenUrl CrossRef PubMed Web of Science
1. Baiardini I,
2. Pasquali M,
3. Braido F,
4. Fumagalli F,
5. Guerra L,
6. Compalati E,
7. et al.
(2005) A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). Allergy 60:1073–1078.
OpenUrl CrossRef PubMed Web of Science
↵
1. Jariwala SP,
2. Moday H,
3. de Asis ML,
4. Fodeman J,
5. Hudes G,
6. de Vos G,
7. et al.
(2009) The urticaria severity score: a sensitive questionnaire/index for monitoring response to therapy in patients with chronic urticaria. Ann Allergy Asthma Immunol 102:475–482.
OpenUrl CrossRef PubMed Web of Science
↵
1. Garcia-Diez I,
2. Curto-Barredo L,
3. Weller K,
4. Pujol RM,
5. Maurer M,
6. Gimenez-Arnau AM
(2015) Cross-cultural adaptation of the urticaria control test from German to Castilian Spanish. Actas Dermosifiliogr 106:746–752.
OpenUrl
↵
1. Kulthanan K,
2. Chularojanamontri L,
3. Tuchinda P,
4. Rujitharanawong C,
5. Maurer M,
6. Weller K
(2016) Validity, reliability and interpretability of the Thai version of the urticaria control test (UCT). Health Qual Life Outcomes 14:61.
OpenUrl
↵
1. Baiardini I,
2. Braido F,
3. Bindslev-Jensen C,
4. Bousquet PJ,
5. Brzoza Z,
6. Canonica GW,
7. et al.
(2011) Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper. Allergy 66:840–844.
OpenUrl PubMed
↵
1. Khan DA
(2008) Chronic urticaria: diagnosis and management. Allergy Asthma Proc 29:439–446.
OpenUrl PubMed
↵
1. Beltrani VS
(2002) An overview of chronic urticaria. Clin Rev Allergy Immunol 23:147–169.
OpenUrl PubMed
↵
1. Demera RS,
2. Ryhal B,
3. Gershwin ME
(2001) Chronic idiopathic urticaria. Compr Ther 27:213–217.
OpenUrl PubMed
↵
1. Poonawalla T,
2. Kelly B
(2009) Urticaria : a review. Am J Clin Dermatol 10:9–21.
OpenUrl PubMed
↵
1. Axelrod S,
2. Davis-Lorton M
(2011) Urticaria and angioedema. Mt Sinai J Med 78:784–802.
OpenUrl PubMed
↵
1. Greaves MW
(2003) Chronic idiopathic urticaria. Curr Opin Allergy Clin Immunol 3:363–368.
OpenUrl PubMed
↵
1. Maurer M,
2. Staubach P,
3. Raap U,
4. Richter-Huhn G,
5. Bauer A,
6. Rueff F,
7. et al.
(2017) H1-antihistamine-refractory chronic spontaneous urticaria: It's worse than we thought - first results of the multicenter real-life AWARE study. Clin Exp Allergy 47:684–692.
OpenUrl
↵
1. Maurer M,
2. Staubach P,
3. Raap U,
4. Richter-Huhn G,
5. Baier-Ebert M,
6. Chapman-Rothe N
(2016) ATTENTUS, a German online survey of patients with chronic urticaria highlighting the burden of disease, unmet needs and real-life clinical practice. Br J Dermatol 174:892–894.
OpenUrl

In this issue

Download PDF

Email Article

Citation Tools

Bookmark this article

Cited By...

No citing articles found.

Google Scholar

More in this TOC Section

Show more Original Article

[1] ↵
Zuberbier T,
Aberer W,
Asero R,
Bindslev-Jensen C,
Brzoza Z,
Canonica GW,
et al.
(2014) The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy 69:868–887.
OpenUrl CrossRef PubMed

[2] Zuberbier T,

[3] Aberer W,

[4] Asero R,

[5] Bindslev-Jensen C,

[6] Brzoza Z,

[7] Canonica GW,

[8] et al.

[9] ↵
Maurer M,
Weller K,
Bindslev-Jensen C,
Gimenez-Arnau A,
Bousquet PJ,
Bousquet J,
et al.
(2011) Unmet clinical needs in chronic spontaneous urticaria. A GA(2)LEN task force report. Allergy 66:317–330.
OpenUrl CrossRef PubMed Web of Science

[10] Maurer M,

[11] Weller K,

[12] Bindslev-Jensen C,

[13] Gimenez-Arnau A,

[14] Bousquet PJ,

[15] Bousquet J,

[16] et al.

[17] ↵
Weller K,
Groffik A,
Church MK,
Hawro T,
Krause K,
Metz M,
et al.
(2014) Development and validation of the urticaria control test: a patient-reported outcome instrument for assessing urticaria control. J Allergy Clin Immunol 133:1365–1372.
OpenUrl CrossRef

[18] Weller K,

[19] Groffik A,

[20] Church MK,

[21] Hawro T,

[22] Krause K,

[23] Metz M,

[24] et al.

[25] ↵
Jauregui I,
Ortiz de Frutos FJ,
Ferrer M,
Gimenez-Arnau A,
Sastre J,
Bartra J,
et al.
(2014) Assessment of severity and quality of life in chronic urticaria. J Investig Allergol Clin Immunol 24:80–86.
OpenUrl

[26] Jauregui I,

[27] Ortiz de Frutos FJ,

[28] Ferrer M,

[29] Gimenez-Arnau A,

[30] Sastre J,

[31] Bartra J,

[32] et al.

[33] ↵
Weller K,
Siebenhaar F,
Hawro T,
Altrichter S,
Schoepke N,
Maurer M
(2017) Clinical measures of chronic urticaria. Immunol Allergy Clin North Am 37:35–49.
OpenUrl

[34] Weller K,

[35] Siebenhaar F,

[36] Hawro T,

[37] Altrichter S,

[38] Schoepke N,

[39] Maurer M

[40] ↵
Weller K,
Zuberbier T,
Maurer M
(2015) Clinically relevant outcome measures for assessing disease activity, disease control and quality of life impairment in patients with chronic spontaneous urticaria and recurrent angioedema. Curr Opin Allergy Clin Immunol 15:220–226.
OpenUrl

[41] Weller K,

[42] Zuberbier T,

[43] Maurer M

[44] ↵
Weller K,
Groffik A,
Magerl M,
Tohme N,
Martus P,
Krause K,
et al.
(2013) Development, validation, and initial results of the Angioedema Activity Score. Allergy 68:1185–1192.
OpenUrl

[45] Weller K,

[46] Groffik A,

[47] Magerl M,

[48] Tohme N,

[49] Martus P,

[50] Krause K,

[51] et al.

[52] ↵
Mlynek A,
Magerl M,
Hanna M,
Lhachimi S,
Baiardini I,
Canonica GW,
et al.
(2009) The German version of the chronic urticaria quality-of-life questionnaire: factor analysis, validation, and initial clinical findings. Allergy 64:927–936.
OpenUrl CrossRef PubMed Web of Science

[53] Mlynek A,

[54] Magerl M,

[55] Hanna M,

[56] Lhachimi S,

[57] Baiardini I,

[58] Canonica GW,

[59] et al.

[60] ↵
Weller K,
Groffik A,
Magerl M,
Tohme N,
Martus P,
Krause K,
et al.
(2012) Development and construct validation of the angioedema quality of life questionnaire. Allergy 67:1289–1298.
OpenUrl PubMed

[61] Weller K,

[62] Groffik A,

[63] Magerl M,

[64] Tohme N,

[65] Martus P,

[66] Krause K,

[67] et al.

[68] ↵
Weller K,
Magerl M,
Peveling-Oberhag A,
Martus P,
Staubach P,
Maurer M
(2016) The angioedema quality of life questionnaire (AE-QoL)–assessment of sensitivity to change and minimal clinically important difference. Allergy 71:1203–1209.
OpenUrl

[69] Weller K,

[70] Magerl M,

[71] Peveling-Oberhag A,

[72] Martus P,

[73] Staubach P,

[74] Maurer M

[75] ↵
Młynek A,
Zalewska-Janowska A,
Martus P,
Staubach P,
Zuberbier T,
Maurer M
(2008) How to assess disease activity in patients with chronic urticaria? Allergy 63:777–780.
OpenUrl CrossRef PubMed Web of Science

[76] Młynek A,

[77] Zalewska-Janowska A,

[78] Martus P,

[79] Staubach P,

[80] Zuberbier T,

[81] Maurer M

[82] Baiardini I,
Pasquali M,
Braido F,
Fumagalli F,
Guerra L,
Compalati E,
et al.
(2005) A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). Allergy 60:1073–1078.
OpenUrl CrossRef PubMed Web of Science

[83] Baiardini I,

[84] Pasquali M,

[85] Braido F,

[86] Fumagalli F,

[87] Guerra L,

[88] Compalati E,

[89] et al.

[90] ↵
Jariwala SP,
Moday H,
de Asis ML,
Fodeman J,
Hudes G,
de Vos G,
et al.
(2009) The urticaria severity score: a sensitive questionnaire/index for monitoring response to therapy in patients with chronic urticaria. Ann Allergy Asthma Immunol 102:475–482.
OpenUrl CrossRef PubMed Web of Science

[91] Jariwala SP,

[92] Moday H,

[93] de Asis ML,

[94] Fodeman J,

[95] Hudes G,

[96] de Vos G,

[97] et al.

[98] ↵
Garcia-Diez I,
Curto-Barredo L,
Weller K,
Pujol RM,
Maurer M,
Gimenez-Arnau AM
(2015) Cross-cultural adaptation of the urticaria control test from German to Castilian Spanish. Actas Dermosifiliogr 106:746–752.
OpenUrl

[99] Garcia-Diez I,

[100] Curto-Barredo L,

[101] Weller K,

[102] Pujol RM,

[103] Maurer M,

[104] Gimenez-Arnau AM

[105] ↵
Kulthanan K,
Chularojanamontri L,
Tuchinda P,
Rujitharanawong C,
Maurer M,
Weller K
(2016) Validity, reliability and interpretability of the Thai version of the urticaria control test (UCT). Health Qual Life Outcomes 14:61.
OpenUrl

[106] Kulthanan K,

[107] Chularojanamontri L,

[108] Tuchinda P,

[109] Rujitharanawong C,

[110] Maurer M,

[111] Weller K

[112] ↵
Baiardini I,
Braido F,
Bindslev-Jensen C,
Bousquet PJ,
Brzoza Z,
Canonica GW,
et al.
(2011) Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper. Allergy 66:840–844.
OpenUrl PubMed

[113] Baiardini I,

[114] Braido F,

[115] Bindslev-Jensen C,

[116] Bousquet PJ,

[117] Brzoza Z,

[118] Canonica GW,

[119] et al.

[120] ↵
Khan DA
(2008) Chronic urticaria: diagnosis and management. Allergy Asthma Proc 29:439–446.
OpenUrl PubMed

[121] Khan DA

[122] ↵
Beltrani VS
(2002) An overview of chronic urticaria. Clin Rev Allergy Immunol 23:147–169.
OpenUrl PubMed

[123] Beltrani VS

[124] ↵
Demera RS,
Ryhal B,
Gershwin ME
(2001) Chronic idiopathic urticaria. Compr Ther 27:213–217.
OpenUrl PubMed

[125] Demera RS,

[126] Ryhal B,

[127] Gershwin ME

[128] ↵
Poonawalla T,
Kelly B
(2009) Urticaria : a review. Am J Clin Dermatol 10:9–21.
OpenUrl PubMed

[129] Poonawalla T,

[130] Kelly B

[131] ↵
Axelrod S,
Davis-Lorton M
(2011) Urticaria and angioedema. Mt Sinai J Med 78:784–802.
OpenUrl PubMed

[132] Axelrod S,

[133] Davis-Lorton M

[134] ↵
Greaves MW
(2003) Chronic idiopathic urticaria. Curr Opin Allergy Clin Immunol 3:363–368.
OpenUrl PubMed

[135] Greaves MW

[136] ↵
Maurer M,
Staubach P,
Raap U,
Richter-Huhn G,
Bauer A,
Rueff F,
et al.
(2017) H1-antihistamine-refractory chronic spontaneous urticaria: It's worse than we thought - first results of the multicenter real-life AWARE study. Clin Exp Allergy 47:684–692.
OpenUrl

[137] Maurer M,

[138] Staubach P,

[139] Raap U,

[140] Richter-Huhn G,

[141] Bauer A,

[142] Rueff F,

[143] et al.

[144] ↵
Maurer M,
Staubach P,
Raap U,
Richter-Huhn G,
Baier-Ebert M,
Chapman-Rothe N
(2016) ATTENTUS, a German online survey of patients with chronic urticaria highlighting the burden of disease, unmet needs and real-life clinical practice. Br J Dermatol 174:892–894.
OpenUrl

[145] Maurer M,

[146] Staubach P,

[147] Raap U,

[148] Richter-Huhn G,

[149] Baier-Ebert M,

[150] Chapman-Rothe N

Main menu

User menu

Search

Chronic urticaria in most patients is poorly controlled

Results of the development, validation, and real life application of the arabic urticaria control test

References

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

CONTENT

JOURNAL

AUTHORS

Main menu

User menu

Search

Chronic urticaria in most patients is poorly controlled

Results of the development, validation, and real life application of the arabic urticaria control test

References

In this issue

Citation Manager Formats

Jump to section

Related Articles

Cited By...

More in this TOC Section

Similar Articles

CONTENT

JOURNAL

AUTHORS